<DOC>
	<DOCNO>NCT00556608</DOCNO>
	<brief_summary>The purpose study prove non-inferiority intra-articular injection hyaluronic acid ( Sinovial® ) symptomatic treatment knee OA comparison Synvisc® .</brief_summary>
	<brief_title>Efficacy Study Intra-articular Hyaluronic Acid Knee Osteoarthritis</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Hyaluronic Acid</mesh_term>
	<mesh_term>Hylan</mesh_term>
	<criteria>Age 40 80 year Primary knee OA medial lateral femorotibial compartment Symptoms least 3 month Diagnosis accord ACR criterion Kellgren &amp; Lawrence radiological grade 23 Patients fail respond sufficiently ( responder ) analgesic and/or NSAIDs take regularly responder intolerant regular use analgesic and/or NSAIDs . Mean WOMAC pain subscore target knee &gt; = 40 mm &lt; 80 mm VAS baseline washout analgesics/NSAIDs· If bilateral knee OA : definition symptomatic joint screen base patient 's evaluation Investigator 's clinical judgment mean WOMAC pain subscore baseline contralateral knee &lt; 30 mm Written inform consent Subject able understand , cooperative reliable BMI &gt; = 32 kg/m2 Secondary ( posttraumatic ) knee OA Predominantly patellofemoral pain/syndrome No remain joint space width Symptomatic hip OA interfere health condition Severe varus/valgus deformity ( &gt; 15° ) History/present evidence ( target knee ) : inflammatory , infective metabolic joint disease ; recurrent clinical chondrocalcinosis ; crystal arthropaties ; osteoarticular pathology differ arthrosis ; articular fracture ; ochronosis ; acromegaly ; haemochromatosis ; Wilson 's disease ; primary osteochondromatosis ; heritable disorder ; collagen gene mutation . Concomitant rheumatic disease Significant injury target knee last 6 month Previous joint replacement/arthroplasty ( target knee ) Arthroscopy/osteotomy/surgery past 1 year ( target knee ) Any surgery schedule next 6 month Venous lymphatic stasis relevant limb Skin infection/disease/trauma injection site Systemic i.a . ( target knee ) corticosteroid past 3 month I.a . corticosteroid ( nontarget joint ) past 4 week Viscosupplementation ( target knee ) past year Recently start ( last 3 month ) physical therapy ( target knee ) Recently ( last 3 month ) start therapy change dosage SYSADOAs Ongoing anticoagulant therapy Chronic recurrent use NSAIDs/analgesics/narcotics diseases different OA target knee History allergy hypersensitivity hyaluronic acid paracetamol avian proteins Participation clinical study last 3 month Pregnant lactating woman , woman childbearing potential willing use adequate contraception Patients unable stay study 6 month , noncooperating , able understand</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2012</verification_date>
</DOC>